Drug Drug Interaction Clinical Trial
Official title:
A Open-Label, Two-sequence Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of Leritrelvir With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin in Healthy Participants
The drug-drug interaction study had been designed to investigate the effect of Leritrelvir on the pharmacokinetics of Midazolam, Omeprazole, Rosuvastatin and the effect of Verapamil and Rifampin on the pharmacokinetics of Leritrelvir
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05574374 -
Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04557397 -
Fruquintinib CYP3A Inhibitor and Inducer Study
|
Phase 1 | |
Completed |
NCT05137600 -
A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06119958 -
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05812404 -
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04606537 -
Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04939467 -
Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04542252 -
Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
|
Phase 1 | |
Enrolling by invitation |
NCT06037564 -
B-free Multistage Trial
|
Phase 4 | |
Completed |
NCT05123820 -
Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470
|
Phase 1 | |
Recruiting |
NCT04840862 -
Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor
|
Phase 4 | |
Completed |
NCT04814498 -
Drug-Drug Interaction (DDI) Study in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01350921 -
Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03103568 -
A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04840641 -
Flucloxacillin as an Inducer of CYP-enzymes
|
Phase 1 | |
Completed |
NCT05304845 -
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
|
Phase 1 | |
Completed |
NCT05845567 -
The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
|
Phase 1 | |
Completed |
NCT05860114 -
Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3)
|
Phase 1 | |
Completed |
NCT04776499 -
Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03909529 -
Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)
|
Phase 1 |